KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT

American global investment company Kohlberg Kravis Roberts & Co (KKR) will acquire all shares of Bushu Pharmaceuticals from Asian private equity firm BPEA EQT for ... Read More